Cell-Based Therapies for Diabetic Complications
Author Information
Author(s): Bernardi Stella, Severini Giovanni Maria, Zauli Giorgio, Secchiero Paola
Primary Institution: University of Ferrara
Hypothesis
Can adult stem and progenitor cells effectively treat diabetic vascular complications?
Conclusion
Cell-based therapies using mesenchymal stem cells and endothelial progenitor cells show promise in treating complications associated with diabetes.
Supporting Evidence
- Diabetic patients show impaired mobilization of adult stem cells from the bone marrow.
- Cell-based therapies may improve vascular repair and regeneration in diabetic patients.
- Endothelial progenitor cells have been shown to support angiogenesis and healing processes.
Takeaway
Scientists are exploring ways to use special cells from adults to help people with diabetes heal better and avoid complications.
Methodology
The review discusses various studies on the use of adult stem and progenitor cells in treating diabetic complications.
Potential Biases
The review does not specify any biases but acknowledges the need for long-term analysis of the therapies.
Limitations
The potential risks of these therapies, including their contribution to lesion formation and the risk of malignant transformation, require further investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website